Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of Alethia Biotherapeutics
Exited company

Alethia Biotherapeutics Inc.

Details
Region
Quebec
Industry sector
Drugs
Investment year
2008
Fund
Healthcare Venture Fund
Learn More
About the company

Alethia is developing innovative therapeutic approaches in areas of unmet medical needs, capitalizing on its capacity to identify and validate disease-specific targets for the development of highly focused monoclonal antibody-based therapeutics. The company is currently focusing on cancer-associated epithelial-to-mesenchymal transition, ovarian cancer, and on cancer-induced bone loss.